From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

"I just liked working with them so much that I joined them," Chen told BioWorld. Today, Chen is co-CEO of WuXi AppTec. The company, which started with a laboratory of 7,000 square feet, has grown into ...

Although a start-up's recent triumph is seen as a 'DeepSeek moment', domestic players still trail world-beating pharma firms, experts say When Zhao Hong, chief doctor of China's leading cancer ...

New work shows that physical folding of the genome to control genes located far away may have been an early evolutionary development.

Your DNA contains millions of genetic variants that interact with each other in ways that affect whether diseases such as schizophrenia and heart disease develop, and with what severity.

One gene causes one trait or a specific illness. When doctors use genetics, it's usually to try to identify a disease-causing gene to help guide diagnosis and treatment. But for most health conditions ...

The genetic roots of a disease or disorder do not always grow into clear cut, easily diagnosed clinical features.

Discover how Bruker and the University of Manchester joined forces to discover more on the dynamics of complex protein.

The Active Pharmaceutical Ingredients Market projected to grow from US$ 238.7 Billion in 2024 to US$ 428.5 Billion by 2033, underscores its pivotal role in modern medicine. With the U.S. leading ...

Lucas Downey is the co-founder of MoneyFlows, and an Investopedia Academy instructor. Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance professor who has been working in ...